Enzymedica GlutenEase 120s

Many people have difficulty digesting gluten and casein proteins commonly found in carbohydrates, resulting in discomforts like occasional gas and bloating. Even those on gluten-free/casein-free diets may experience difficulties due to cross-contamination from offending foods.
$104.50 NZD $89.99 NZD
Enzymedica GlutenEase 120s
Specials are for online purchases only, don't miss out! - Email us to check for availability.

Recommended Use: 1 capsule with each meal containing gluten or casein. More may be taken as needed. 

This product is not intended to replace a gluten-free diet for individuals with Celiac Disease. 

Recommended Use: 1 capsule with each meal. More may be taken as needed. 

GlutenEase™ -  - 1

Thera-blend™ is an exclusive process that combines multiple strains of enzymes that work in various pH levels. Thera-blend enzymes have been shown to be three times stronger and work more than six times faster than leading digestive supplements.* 

Our Story

Enzymedica is a Florida company that was founded in 1998 with the purpose of offering our customers the highest-potency enzyme products possible. Today, as one of the leaders in the industry, we still strive for no less.

We believe knowledge has the power to change lives. Our goal of educating people about the importance of enzymes in overall health is what motivates Enzymedica every day.

All of our products are made from only the highest quality enzymes and contain absolutely no fillers to ensure purity. Every product is 100% vegetarian, and we seek out vegan and Kosher ingredients whenever possible. Each product is specifically formulated to provide targeted support for common digestive discomforts, food intolerances, cardiovascular health, proper immune function or healthy inflammatory responses.

Enzymedica’s Quality Pledge
We respect consumers’ desire to make healthy dietary choices. Enzymedica routinely tests our products for gluten and other ingredients in accordance with cGMP guidelines.

has been added to cart.

What's Next?